HOXA11 and cancer: Upregulation of HOXA11-AS is significantly associated with poor prognosis of LSCC patients, while downregulation in LSCC cell lines is connected with inhibition of the invasion and migration of cancer cells, suggesting an oncogenic role of HOXA11-AS (Qu et al. 2018).